Feedback / Questions
neldaleucel (MT-601) - Marker Therap
https://www.globenewswire.com/news-release/2025/08/26/3139146/0/en/Marker-Therapeutics-Provides-Update-on-Phase-1-APOLLO-Study-Highlighting-Encouraging-Overall-Response-Rates-in-Relapsed-Lymphoma.html
Aug 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next